Penta - Child Health Research

Today is #InternationalWomen'sDay & we stand with the theme: Rights. Justice. Action.

Watch to find out what defines the women of the Penta ID Network & their vital role in helping us realise our vision where the health needs of pregnant people, infants, children & adolescents are prioritised!

📌 How do #IPC practices vary across European NICUs?

Join the #NeoIPC/#UENPS webinar “Neonatal Infection Prevention in Europe: Findings from the NeoIPC-UENPS Survey”
🗓️ 5 March | 13:00–14:00 CET

Discover key insights drawing from 200 responses.
Register 👉 www.mcascientificevents.eu/neobestpract...

@bsky.app Why do some children and pregnant women not get vaccinated?
Hint: It’s not a lack of trust in science.

Helen Skirrow, the recipient of the 2026 BFA Young Researcher Award, shows how sharing power with communities drives real vaccine uptake in the UK.

Congratulations, Helen.

🧵3/3

Today, let’s choose words that open doors instead of building walls.

#PentaFoundation #ZeroDiscrimination #PeopleFirst #EndStigma #HealthEquity

🧵 2/3
When we say a "child living with HIV" instead of an "HIV-infected child," we acknowledge the person before the virus. This simple shift helps break down the stigma that can prevent families from seeking the care they need.

🧵1/3
On #ZeroDiscriminationDay, we are following the global lead to put People First. 🦋

At Penta, we believe that language is the foundation of dignity. This isn't about being politically correct, it’s about ensuring that a medical condition never overshadows a child’s identity.

Catch Anna Turkova & Simon Drysdale on Feb 19 (13:20-13:50) at the RSVVW’26 conference to discuss the PIPELINE-RSV trial.

Learn how PIPELINE aims to use adaptive trials to improve #RSV preparedness for pregnant people and infants across Europe.

More 👉 https://resvinet.org/conferences/rsvvw26/

Home - SNIP-AFRICA SNIP-AFRICA is an African-European collaboration that aims to improve the way severe infections in newborns are treated. Using an innovative approach, SNIP-AFRICA will tackle questions around antibiot...

Around 600 babies in Kenya will take part in this landmark trial, which also forms part of the @globalhealthedctp3.bsky.social funded, Penta-led SNIP-AFRICA consortium which aims to reduce mortality among newborns with sepsis in African hospitals.

Learn mora about SNIP-AFRICA 👉 www.snip-africa.org

Treating neonatal sepsis YouTube video by Penta Child Health Research

🧵
📢 NEWS: Kenya joins @gardp.bsky.social NeoSep1 Part 2 trial on #NeonatalSepsis.

The trial has started enrolling newborn babies with #sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi). 🇰🇪

Today is the #InternationalDayOfWomenAndGirlsInScience, and we asked the women within the Penta ID Network to share a message for girls who are interested in STEM but are hesitant to take that step.

Watch for a dose of inspiration from the women leading by example.

@academicmededu.bsky.social

📢 Call for Abstracts: 𝟭𝟴𝘁𝗵 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗼𝗻 #PediatricsHIV 𝟮𝟬𝟮𝟲! Submission deadline: 17 April 2026.

Join fellow researchers and clinicians to advance #HIV prevention and treatment for infants, children and adolescents.

🔗 Learn more and submit your abstract: lnkd.in/d43EaECG

@isi.it @mrcctu.bsky.social @citystgeorges.bsky.social @ecraid.bsky.social @umcutrecht.bsky.social @ucl.ac.uk @uantwerpen.be @ehess.fr @upcite.bsky.social @ec.europa.eu

Big news from the PIPELINE team!

We’ve officially recruited our first participant into the PIPELINE RSV-International trial.

This milestone marks the start of an important chapter bringing us closer to providing better protection against RSV in infants.

More 👉 bit.ly/3O3qsdP

⏰ Last chance to submit your abstract for the 3rd Conference on Innovations in Tuberculosis - highlighting TB research and innovation in African contexts, where the burden is greatest but voices are too often underrepresented.

Info & submit abstract ➡️ bit.ly/4tmOp00

@academicmededu.bsky.social

The #ENABLE kick-off meeting is underway in South Africa! @globalhealthedctp3.bsky.social

Penta will coordinate Ethics & Regulatory work for a trial testing 2 #bNAbs as intensification therapy alongside oral #ART in high-risk infants with #HIV 👶🏽

Excited to be part of this impactful project 🥰

Right-sizing antibiotic treatment, highlights from the PediSEP-1 kick-off meeting - PediSEP-1 From January 19–20, 2026, the PediSEP-1 consortium gathered in Mombasa, Kenya, for the official launch the project, designed to move paediatric care away from a “one-size-fits-all” approach and toward...

Did you know that low-risk children often receive the same antibiotic treatment as high-risk patients? This is because we lack clear data on when to safely stop care

PediSEP-1 aims to change that and provide the missing data, inform policy change and protect children from #AMR!

@ecraid.bsky.social

@isi.it

@mrcctu.bsky.social

@upcite.bsky.social

@umcutrecht.bsky.social

@uantwerpen.be

@inserm.fr

PIPELINE RSV International has officially opened its first site!

Can we better protect babies and pregnant people from #RSV? PIPELINE RSV hopes to answer this.

Swipe to learn more!

Read the full announcement here 👉 bit.ly/45mhtdH

📈 New NeoSep1 results!

Part 1 shows that fosfomycin and flomoxef are safe and well-tolerated in babies with sepsis. Part 2, designed by our experts, compares antibiotic combinations for treating neonatal sepsis.

@pentafoundation.bsky.social @gardp.bsky.social

Read more about it 👇

@bhiva.bsky.social @eacsociety.bsky.social #ESPID #CHIVA @unipd.bsky.social @academicmededu.bsky.social

📣 Healthcare professionals: level up your expertise in #HIV & congenital infections 🇮🇹!

🎓 PentaTr@ining course (hybrid): online modules + expert webinars + in-person workshop in Padova, Italy
🗓 Online Apr–Jul 2026 | Residential Sept 2026
🔗 Register now 👉 penta-id.org/hiv-other-co...

Good news for newborn health 👶

New findings from GARDP's #NeoSep1 trial show that off-patent antibiotics, fosfomycin & flomoxef, are safe in newborns with sepsis, supporting affordable treatment options where #AMR burden is highest

🔗 bit.ly/45oK3v1

@pentafoundation.bsky.social
@mrcctu.bsky.social

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1) | Antimicrobial Agents and Chemotherapy Infections are prevalent during the first month of life and represent one of the leading causes of neonatal mortality worldwide (1). In 2017, an estimated 1.3 million cases of neonatal sepsis were rep...

Read the article published in Antimicrobial Agents and Chemotherapy ➡️ journals.asm.org/doi/10.1128/...

Home - SNIP-AFRICA SNIP-AFRICA is an African-European collaboration that aims to improve the way severe infections in newborns are treated. Using an innovative approach, SNIP-AFRICA will tackle questions around antibiot...

The #NeoSep1 clinical trial is sponsored by @gardp.bsky.social in collaboration with @mrcctu.bsky.social, @citystgeorges.bsky.social and Penta.

The trial is also part of the #SNIP-AFRICA project, an African-European collaboration funded by @globalhealthedctp3.bsky.social & led by Penta.

NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis - SNIP-AFRICA A paper published in the journal Antimicrobial Agents and Chemotherapy (AAC) reports that off-patent antibiotics, fosfomycin and flomoxef, when used at standard doses, were safe in newborn babies with...

Every year, sepsis claims hundreds of thousands of newborn lives, but new evidence offers hope. 👶

#NeoSep1 Part 1 shows off-patent antibiotics fosfomycin and flomoxef are safe and well tolerated in newborns with suspected #sepsis, including high-risk preterm infants. 💜

👇

This year’s theme reminds us that science works only when systems and communities do. Progress relies on investment, rights-based care & community leadership.

Thank you to everyone on the front lines, and to the teams behind the scenes, who make the response resilient.

@unaids.org #EndAIDS

On #WorldAIDSDay2025, we recognise the extraordinary efforts of the people who turn evidence into impact, researchers, clinicians and community leaders across the globe.

⬇️

@gardp.bsky.social
@mrcctu.bsky.social
@citystgeorges.bsky.social
@globalhealthedctp3.bsky.social
@theguardian.com

Antibiotic resistance: how a pioneering trial is using old drugs to save babies from sepsis The infection is responsible for 800,000 newborn deaths each year, but clinics in eight countries are working together to find new treatments

Old drugs, new hope.
Instead of waiting decades for new antibiotics, #NeoSep1 is rethinking the ones we already have to treat newborn sepsis more safely and effectively. 🩷

In Africa, the trial is a key pillar of #SNIPAFRICA, funded by EDCTP3 and led by Penta. 🔗 snip-africa.org

📰 Guardian feature 👇